Curated Video
Barbara McClintock: Scientific Persistence Pays Off
Barbara McClintock used corn to make pioneering discoveries in genetics, despite facing gender bias and initial skepticism from the scientific community.
The Wall Street Journal
Silicon Valley's Green Thumb
Entrepreneurs who want to deploy tech-industry tools in the Farm Belt are getting billions of dollars in investment from venture capital firms and food companies. But profits are elusive.
The Wall Street Journal
Rethinking Health Policy in the Age of Coronavirus
At the 2020 WSJ Health Forum, Chief Economics Commentator Greg Ip spoke with MIT Sloan School of Management's Dr. Simon Johnson and Johns Hopkins Bloomberg School of Health's Dr. Joshua Sharfstein on the public health gaps COVID-19 has...
The Wall Street Journal
Plant Tinkerers
A new generation of startups are harnessing gene-editing technologies to take on the multibillion-dollar giants of the crop-seed industry. Will consumers buy in?
The Wall Street Journal
Investing in Global Health
At the 2020 WSJ Health Forum, New York State Department of Health Commissioner Dr. Howard Zucker spoke with Health & Science Bureau Chief Stefanie Ilgenfritz about lessons we can apply from this pandemic to fighting the next superbug.
The Wall Street Journal
Deep Dive: The Big Shift in AI-Driven Care
Can algorithms trained on data detect and diagnose diseases like Covid-19 better than humans? Tech executives discuss the potential of AI-driven tools to help in detecting and preventing medical conditions.
The Wall Street Journal
Food Rx: A Perspective
The connections between obesity, malnutrition and climate change.
The Wall Street Journal
Chasing Cures
At the 2020 WSJ Health Forum, Reporter Amy Dockser Marcus spoke with Center for Genetics Executive Director Dr. Marcy Darnovsky and Dr. Todd Kuiken, senior research scholar at NC State, about scientists' right to pursue controversial...
The Wall Street Journal
The Cost of the Cure
At the 2020 WSJ Health Forum, FDA Principal Deputy Commissioner Dr. Amy P. Abernethy spoke with Reporter Peter Loftus about how regulators and companies can make the drug development process more efficient without compromising safety.